Global Meningococcal Vaccine Competitive Landscape Professional Research Report 2025
Research Summary
The meningococcal vaccine is a type of immunization that helps protect against meningococcal disease, which is caused by the bacterium Neisseria meningitidis. Meningococcal disease can lead to severe infections like meningitis (inflammation of the membranes surrounding the brain and spinal cord) and septicemia (bloodstream infection). The vaccine stimulates the body’s immune system to produce a response against the specific strains of meningococcal bacteria included in the vaccine. There are different types of meningococcal vaccines available, including those targeting serogroups A, B, C, W, and Y. Some vaccines are conjugate vaccines, which offer longer-lasting protection and are often recommended for infants, adolescents, and young adults. Other vaccines may target specific high-risk populations or outbreaks. The meningococcal vaccine is typically administered through injection, and receiving the vaccine helps reduce the risk of meningococcal disease and its potentially severe complications. It is often recommended for individuals at increased risk, such as adolescents, college students living in dormitories, military recruits, and travelers to areas with high meningococcal disease rates.
According to DIResearch's in-depth investigation and research, the global Meningococcal Vaccine market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Meningococcal Vaccine include Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med, China National Biotec Group, Hualan Bio, Zhifei, Walvax etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Meningococcal Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Meningococcal Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Meningococcal Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Meningococcal Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Meningococcal Vaccine Include:
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Zhifei
Walvax
Meningococcal Vaccine Product Segment Include:
Meningtits A
Polysaccharide Meningtitis AC
Meningitis ACYW
Meningococcal Vaccine Product Application Include:
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Meningococcal Vaccine Industry PESTEL Analysis
Chapter 3: Global Meningococcal Vaccine Industry Porter’s Five Forces Analysis
Chapter 4: Global Meningococcal Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Meningococcal Vaccine Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Meningococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Meningococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Meningococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Meningococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Meningococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Meningococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Meningococcal Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Meningococcal Vaccine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Meningococcal Vaccine Product by Type
- 1.2.1 Meningtits A
- 1.2.2 Polysaccharide Meningtitis AC
- 1.2.3 Meningitis ACYW
- 1.3 Meningococcal Vaccine Product by Application
- 1.3.1 6 Months-15Year
- 1.3.2 over 3 Year
- 1.3.3 over 2 Year
- 1.3.4 over 3 Months
- 1.4 Global Meningococcal Vaccine Market Revenue and Sales Analysis
- 1.4.1 Global Meningococcal Vaccine Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Meningococcal Vaccine Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Meningococcal Vaccine Market Sales Price Trend Analysis (2020-2032)
- 1.5 Meningococcal Vaccine Industry Trends and Innovation
- 1.5.1 Meningococcal Vaccine Industry Trends and Innovation
- 1.5.2 Meningococcal Vaccine Market Drivers and Challenges
- 2 Meningococcal Vaccine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Meningococcal Vaccine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Meningococcal Vaccine Market Analysis by Regions
- 4.1 Meningococcal Vaccine Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Meningococcal Vaccine Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Meningococcal Vaccine Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Meningococcal Vaccine Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Meningococcal Vaccine Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Meningococcal Vaccine Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Meningococcal Vaccine Sales Forecast by Region (2026-2032)
- 4.4 Global Meningococcal Vaccine Sales Price Trend Analysis (2020-2032)
- 5 Global Meningococcal Vaccine Market Size by Type and Application
- 5.1 Global Meningococcal Vaccine Market Size by Type
- 5.1.1 Global Meningococcal Vaccine Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Meningococcal Vaccine Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Meningococcal Vaccine Market Size by Application
- 5.2.1 Global Meningococcal Vaccine Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Meningococcal Vaccine Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Meningococcal Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Meningococcal Vaccine Market Size by Type
- 6.3.1 North America Meningococcal Vaccine Sales by Type (2020-2032)
- 6.3.2 North America Meningococcal Vaccine Revenue by Type (2020-2032)
- 6.4 North America Meningococcal Vaccine Market Size by Application
- 6.4.1 North America Meningococcal Vaccine Sales by Application (2020-2032)
- 6.4.2 North America Meningococcal Vaccine Revenue by Application (2020-2032)
- 6.5 North America Meningococcal Vaccine Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Meningococcal Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Meningococcal Vaccine Market Size by Type
- 7.3.1 Europe Meningococcal Vaccine Sales by Type (2020-2032)
- 7.3.2 Europe Meningococcal Vaccine Revenue by Type (2020-2032)
- 7.4 Europe Meningococcal Vaccine Market Size by Application
- 7.4.1 Europe Meningococcal Vaccine Sales by Application (2020-2032)
- 7.4.2 Europe Meningococcal Vaccine Revenue by Application (2020-2032)
- 7.5 Europe Meningococcal Vaccine Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Meningococcal Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Meningococcal Vaccine Market Size by Type
- 8.3.1 China Meningococcal Vaccine Sales by Type (2020-2032)
- 8.3.2 China Meningococcal Vaccine Revenue by Type (2020-2032)
- 8.4 China Meningococcal Vaccine Market Size by Application
- 8.4.1 China Meningococcal Vaccine Sales by Application (2020-2032)
- 8.4.2 China Meningococcal Vaccine Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Meningococcal Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Meningococcal Vaccine Market Size by Type
- 9.3.1 APAC (excl. China) Meningococcal Vaccine Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Meningococcal Vaccine Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Meningococcal Vaccine Market Size by Application
- 9.4.1 APAC (excl. China) Meningococcal Vaccine Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Meningococcal Vaccine Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Meningococcal Vaccine Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Meningococcal Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Meningococcal Vaccine Market Size by Type
- 10.3.1 Latin America Meningococcal Vaccine Sales by Type (2020-2032)
- 10.3.2 Latin America Meningococcal Vaccine Revenue by Type (2020-2032)
- 10.4 Latin America Meningococcal Vaccine Market Size by Application
- 10.4.1 Latin America Meningococcal Vaccine Sales by Application (2020-2032)
- 10.4.2 Latin America Meningococcal Vaccine Revenue by Application (2020-2032)
- 10.5 Latin America Meningococcal Vaccine Market Size by Country
- 10.6 Latin America Meningococcal Vaccine Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Meningococcal Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Meningococcal Vaccine Market Size by Type
- 11.3.1 Middle East & Africa Meningococcal Vaccine Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Meningococcal Vaccine Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Meningococcal Vaccine Market Size by Application
- 11.4.1 Middle East & Africa Meningococcal Vaccine Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Meningococcal Vaccine Revenue by Application (2020-2032)
- 11.5 Middle East Meningococcal Vaccine Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Meningococcal Vaccine Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Meningococcal Vaccine Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Meningococcal Vaccine Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Meningococcal Vaccine Average Sales Price by Manufacturers (2021-2025)
- 12.2 Meningococcal Vaccine Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Meningococcal Vaccine Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Novartis
- 13.1.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Novartis Meningococcal Vaccine Product Portfolio
- 13.1.3 Novartis Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 GSK
- 13.2.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 GSK Meningococcal Vaccine Product Portfolio
- 13.2.3 GSK Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Merck
- 13.3.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Merck Meningococcal Vaccine Product Portfolio
- 13.3.3 Merck Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 CSL
- 13.4.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 CSL Meningococcal Vaccine Product Portfolio
- 13.4.3 CSL Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Baxter
- 13.5.1 Baxter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Baxter Meningococcal Vaccine Product Portfolio
- 13.5.3 Baxter Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 JN International Medical Corporation
- 13.6.1 JN International Medical Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 JN International Medical Corporation Meningococcal Vaccine Product Portfolio
- 13.6.3 JN International Medical Corporation Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 Serum Institute of India
- 13.7.1 Serum Institute of India Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Serum Institute of India Meningococcal Vaccine Product Portfolio
- 13.7.3 Serum Institute of India Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Bio-Med
- 13.8.1 Bio-Med Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Bio-Med Meningococcal Vaccine Product Portfolio
- 13.8.3 Bio-Med Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 China National Biotec Group
- 13.9.1 China National Biotec Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 China National Biotec Group Meningococcal Vaccine Product Portfolio
- 13.9.3 China National Biotec Group Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 Hualan Bio
- 13.10.1 Hualan Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Hualan Bio Meningococcal Vaccine Product Portfolio
- 13.10.3 Hualan Bio Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.11 Zhifei
- 13.11.1 Zhifei Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Zhifei Meningococcal Vaccine Product Portfolio
- 13.11.3 Zhifei Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.12 Walvax
- 13.12.1 Walvax Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Walvax Meningococcal Vaccine Product Portfolio
- 13.12.3 Walvax Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Meningococcal Vaccine Industry Chain Analysis
- 14.2 Meningococcal Vaccine Industry Raw Material and Suppliers Analysis
- 14.2.1 Meningococcal Vaccine Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Meningococcal Vaccine Typical Downstream Customers
- 14.4 Meningococcal Vaccine Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook